pfnx is a nice play but i like dyai's prospects better. dyai has more going for them as far as a platform goes if things come to fruition. their success in glyco engineering has still gone over the heads of wall st. they are not getting the recognition for what they just accomplished. also, if they can prove their AAV platform, things will really get exciting. remember, big pharma bought company for close to a billion just for their glyyco programs which appear to be inferior to dyai's. now add all of the other programs dyai has, you'd have to think this company is worth more than a billion. i believe big pharma knows what they are doing, as many are working with dyai. they also understand the significance of the recent results of glyco. i don;t think it will be much longer before things really start to get going
News 
Market Data 
Discover 
